Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Human insulin like growth factor binding protein 2 (IGFBP-2) ELISA kit (0.313-20 ng/mL)
Cat. No.:
0126WXX-477
Assay Type:
Quantitative sandwich ELISA
Target Species:
Human
Assay Target:
IGFBP-2
Size:
Add to basket
Product Overview
Description:
Human insulin like growth factor binding protein 2 (IGFBP-2) ELISA kit (0.313-20 ng/mL) is an ELISA-based in vitro research tool designed specifically for the quantitative detection of IGFBP-2 in human samples with a range of 0.313-20 ng/mL and a minimum detectable dose (sensitivity) of 0.188 ng/mL. The kit is highly sensitive and easy to use.
Assay Principle:
This kit is based on sandwich ELISA technology. An anti-human IGFBP-2 antibody is pre-coated onto 96-well plates. A biotin-conjugated detection antibody and test samples are added sequentially. After washing with the wash buffer, HRP-streptavidin is introduced. TMB substrates are used to visualize the HRP enzymatic reaction, producing a blue product that turns yellow upon the addition of an acidic stop solution. The yellow intensity is proportional to the human IGFBP-2 concentration, which is calculated by reading the O.D. at 450 nm.
Background:
IGFBP-2 is a multifunctional molecule that plays a crucial role in human growth, metabolism, and cellular processes by regulating the biological activity of insulin-like growth factors (IGFs). Primarily through binding to IGF proteins, IGFBP-2 prolongs their half-life in the body and modulates their interactions with cell surface receptors, thereby inhibiting or enhancing the pro-growth effects of IGFs. The role of IGFBP-2 in obesity has garnered increasing attention. Its reduced levels are closely associated with obesity, dyslipidemia, and insulin resistance.
Synonyms:
IBP-2; IGF-binding protein 2; IGFBP2; BP2, IBP2; Insulin-Like Growth Factor Binding Protein 2, 36kDa; Insulin-Like Growth Factor-Binding Protein 2
Applications:
Human insulin like growth factor binding protein 2 (IGFBP-2) ELISA kit (0.313-20 ng/mL) is used to quantify IGFBP-2 in serum, plasma, cell culture supernatant, cell, tissue lysate, and other liquid samples of human, providing data to support research in a wide range of areas, including immunity, endocrinology, signal transduction, obesity, and others.
Research Area:
Immunity; Endocrinology; Signal transduction; Obesity
Specification
Sample Type:
Serum; Plasma; Cell culture supernatant; Cell; Tissue lysate; Other liquid samples
Detection Range:
0.313-20 ng/mL
Sensitivity:
0.188 ng/mL
Cross-reactivity:
No significant cross-reactivity or interference was observed.
Recovery:
92-99%
Storage:
Store at -20°C (microplate, standard) and 2-8°C (other reagents).


